| NCT Number | NCT07710846 |
| Lead Sponsor | Regeneron Pharmaceuticals |
| Conditions | Conjunctivitis Allergic |
| Enrollment | 1,500 participants |
| Start Date | 2026-08-17 |
| Primary Completion | 2028-01-10 (estimated) |
| Study Completion | 2028-01-10 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-17 |